Avanos Medical, INC. 8-K/A Filing
Ticker: AVNS · Form: 8-K/A · Filed: Dec 5, 2025 · CIK: 1606498
Sentiment: neutral
Filing Stats: 910 words · 4 min read · ~3 pages · Grade level 11.2 · Accepted 2025-12-05 16:03:07
Key Financial Figures
- $0.01 — nge on which registered Common Stock - $0.01 Par Value AVNS New York Stock Exchange
- $1,535,417 — pay Mr. Holbrook a severance payment of $1,535,417 and Ms. James a severance payment of $1
- $1,425,665 — 17 and Ms. James a severance payment of $1,425,665. The Company will also pay 100% of Mr.
Filing Documents
- avns-20251021.htm (8-K/A) — 29KB
- avns-20251021_g1.jpg (GRAPHIC) — 15KB
- 0001606498-25-000135.txt ( ) — 186KB
- avns-20251021.xsd (EX-101.SCH) — 2KB
- avns-20251021_lab.xml (EX-101.LAB) — 22KB
- avns-20251021_pre.xml (EX-101.PRE) — 13KB
- avns-20251021_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVANOS MEDICAL, INC. Date: December 5, 2025 By: /s/ John J. Hurley John J. Hurley Controller